Regressive melanoma with lichenoid tissue reaction may be clinically and histopathologically challenging. A 73-year-old male visited our clinic for a general skin checkup. We noticed a red papule on the right side of his back. On dermatoscopy, scattered grayish dots were observed. The differential diagnosis included lichenoid keratosis and melanoma. Histopathological examination of the excised lesion showed a regressive melanoma with a histopathological pattern of lichenoid keratosis.

A 73-year-old male with a history of hypertensive nephrosclerosis leading to terminal chronic renal insufficiency and renal allograft underwent his annual skin checkup in our clinic. A red papule was noticed on the right side of the back (Fig. 1). On dermatoscopy, we observed grayish dots scattered in the center and the periphery of the lesion. The clinical differential diagnosis was lichenoid keratosis or malignant melanoma. The lesion was surgically removed.

Fig. 1.

Red papule on the right side of the back.

Fig. 1.

Red papule on the right side of the back.

Close modal

The biopsy material obtained from the patient was fixed in formalin, embedded in paraffin, cut at 5 μm, and stained with hematoxylin-eosin.

Histopathological examination revealed a dense dermal lymphocytic infiltrate with a lichenoid pattern containing melanophages, vacuolar degeneration and necrosis of basal keratinocytes, and a proliferation of atypical melanocytes showing pagetoid spread within the epidermis, confirmed by Melan-A staining (Fig. 2). A diagnosis of regressive melanoma with a histopathological pattern of lichenoid keratosis was made.

Fig. 2.

Dermal lymphocytic infiltrate with a lichenoid pattern and proliferation of atypical melanocytes showing pagetoid spread within the epidermis, confirmed by Melan-A staining.

Fig. 2.

Dermal lymphocytic infiltrate with a lichenoid pattern and proliferation of atypical melanocytes showing pagetoid spread within the epidermis, confirmed by Melan-A staining.

Close modal

Lichenoid keratosis or lichen planus-like keratosis has been proposed to be a regressive epidermal lesion such as solar lentigo or seborrheic keratosis. Usually, this lesion is localized on the trunk, but less frequently on the extremities, head, and neck. The clinical aspect is a red-brown papule. The most common dermatoscopic finding is a granular pattern (reddish-brown, bluish-gray, or whitish-gray granules) [1].

Regressive melanoma can be clinically and dermatoscopically indistinguishable from lichenoid keratosis. The presence of a single lesion showing clinical features of lichenoid keratosis should raise the concern of a melanoma undergoing regression [2, 3].

Multiple blue-grey dots are found in 45% of invasive melanoma and have a specificity of 91%. It corresponds histopathologically to melanophages in the early-intermediate phase of regression. The other differential diagnoses are basal cell carcinoma, seborrheic keratosis, actinic keratosis, Bowen’s disease, and invasive squamous cell carcinoma.

Histopathological examination should be thoroughly performed and include immunohistochemistry to search for the potential signs of melanoma, such as pagetoid spread of atypical melanocytes within the epidermis [4].

Immunohistochemical analysis is necessary to avoid missing a melanoma showing clinical and histopathological features of lichenoid keratosis.

This case report was prepared in compliance with all ethical and confidentiality guidelines and principles. The authors obtained informed oral consent from the patient’s wife as it was not practical to have it in writing because of her advanced age. The authors consulted the President of the Ethical Commission on Human Research in Geneva who approved the consent procedure.

The authors have no conflicts of interest to declare.

No funding was received.

M.S. and Y.L.I. contributed to the acquisition, analysis, and interpretation of the data for the work, participated in drafting the work, approved the final version to be published, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. G.K. made substantial contributions to the conception and design of the work and to the acquisition, analysis, and interpretation of the data for the work; participated in drafting the work, revising it critically for important intellectual content, approved the final version to be published, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

1.
Zaballos
P
,
Blazquez
S
,
Puig
S
,
Salsench
E
,
Rodero
J
,
Vives
JM
, et al.
Dermoscopic pattern of intermediate stage in seborrhoeic keratosis regressing to lichenoid keratosis: report of 24 cases
.
Br J Dermatol
.
2007
Aug
;
157
(
2
):
266
72
.
[PubMed]
0007-0963
2.
Raptoulis
G
,
Spencer
R
,
Einstein
B
,
Oliviero
M
,
Braun
R
,
Rabinovitz
H
.
Lichen planus-like keratosis of the face: a simulator of melanoma in situ
.
Dermatol Surg
.
2007
Jul
;
33
(
7
):
854
6
.
[PubMed]
1076-0512
3.
Moscarella
E
,
Zalaudek
I
,
Pellacani
G
,
Eibenschutz
L
,
Catricalà
C
,
Amantea
A
, et al.
Lichenoid keratosis-like melanomas
.
J Am Acad Dermatol
.
2011
Sep
;
65
(
3
):
e85
7
.
[PubMed]
0190-9622
4.
Dalton
SR
,
Fillman
EP
,
Altman
CE
,
Gardner
TL
,
Davis
TL
,
Bastian
BC
, et al.
Atypical junctional melanocytic proliferations in benign lichenoid keratosis
.
Hum Pathol
.
2003
Jul
;
34
(
7
):
706
9
.
[PubMed]
0046-8177
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.